Leaflet IVABRADINA MYLAN 7.5mg film-coated tablets

Product code:
W63727021
Quantity:
100
Indicated for:
angina pectoris; heart failure
Route of administration:
oral
Substance:
ivabradine (antihypertensive)
ATC
C01EB17 — Cardiovascular system | Other cardiac preparations
Ivabradine is a medication used to treat stable angina (chest pain caused by reduced blood flow to the heart) and chronic heart failure. It works by reducing the heart rate without affecting the strength of heart contractions, which helps decrease the heart's oxygen demand and improve cardiac function.

It is particularly indicated for patients who cannot tolerate beta-blockers or those who require additional treatment to control heart rate. Ivabradine is effective in reducing angina symptoms and lowering the risk of hospitalization due to heart failure.

Side effects may include visual disturbances (perception of bright lights), bradycardia (slowed heart rate), dizziness, fatigue, or headaches. It is important for the medication to be taken as prescribed by a doctor, and patients should be monitored to avoid complications.

General data about IVABRADINA MYLAN 7.5mg

Substance:
ivabradine
Date of latest medicines list:
16-08-2017
Product code:
W63727021
Concentration:
7.5mg
Pharmaceutical form:
film-coated tablets
Quantity:
100
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
COMBINO PHARM LTD. - MALTA
Holder:
MYLAN S.A.S. - FRANTA
Number:
10086/2017/21
Shelf life:
18 months; after the first opening of the bottle-6 months

Concentrations available for ivabradine

  • 5mg
  • 7.5mg

Combinations with other substances